These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 25809698)
1. Erectile dysfunction and phosphodiesterase type 5 inhibitor use: associations with sexual activities, function and satisfaction in a population sample of older men. Lee DM; Nazroo J; Pendleton N Int J Impot Res; 2015 Jul; 27(4):146-51. PubMed ID: 25809698 [TBL] [Abstract][Full Text] [Related]
2. The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. Fisher WA; Rosen RC; Eardley I; Niederberger C; Nadel A; Kaufman J; Sand M J Sex Med; 2004 Sep; 1(2):150-60. PubMed ID: 16422969 [TBL] [Abstract][Full Text] [Related]
3. Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. Fisher WA; Rosen RC; Eardley I; Sand M; Goldstein I J Sex Med; 2005 Sep; 2(5):675-84. PubMed ID: 16422826 [TBL] [Abstract][Full Text] [Related]
4. The impact of the use of PDE5 inhibitors for erectile dysfunction on the lives of Australian men. Matic H; McCabe MP Int J Impot Res; 2007; 19(4):418-23. PubMed ID: 17538638 [TBL] [Abstract][Full Text] [Related]
6. Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors. Schnetzler G; Banks I; Kirby M; Zou KH; Symonds T J Sex Med; 2010 Mar; 7(3):1237-46. PubMed ID: 20136707 [TBL] [Abstract][Full Text] [Related]
7. Impact of a first treatment with phosphodiesterase inhibitors on men and partners' quality of sexual life: results of a prospective study in primary care. Costa P; Grandmottet G; Mai HD; Droupy S J Sex Med; 2013 Jul; 10(7):1850-60. PubMed ID: 23679019 [TBL] [Abstract][Full Text] [Related]
8. An Evaluation of a Clinical Care Pathway for the Management of Men With Nonorganic Erectile Dysfunction. Jenkins LC; Hall M; Deveci S; Guhring P; Parker M; Nelson CJ; Mulhall JP J Sex Med; 2019 Oct; 16(10):1541-1546. PubMed ID: 31444103 [TBL] [Abstract][Full Text] [Related]
9. 2009 update on phosphodiesterase type 5 inhibitor therapy part 2: updates on optimal utilization for sexual concerns and rare toxicities in this class. Shindel AW J Sex Med; 2009 Sep; 6(9):2352-64; quiz 2365-6. PubMed ID: 19735356 [TBL] [Abstract][Full Text] [Related]
10. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension. Jones LA; Klimberg IW; McMurray JG; Padula R; Tseng LJ; Stecher VJ J Sex Med; 2008 Aug; 5(8):1955-64. PubMed ID: 18564150 [TBL] [Abstract][Full Text] [Related]
11. Potential for Long-Term Benefit of Cognitive Behavioral Therapy as an Adjunct Treatment for Men with Erectile Dysfunction. Khan S; Amjad A; Rowland D J Sex Med; 2019 Feb; 16(2):300-306. PubMed ID: 30770073 [TBL] [Abstract][Full Text] [Related]
12. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra). Montorsi F; Padma-Nathan H; Glina S Urology; 2006 Sep; 68(3 Suppl):26-37. PubMed ID: 17011373 [TBL] [Abstract][Full Text] [Related]
13. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial. Goldstein I; Fisher WA; Sand M; Rosen RC; Mollen M; Brock G; Karlin G; Pommerville P; Bangerter K; Bandel TJ; Derogatis LR; J Sex Med; 2005 Nov; 2(6):819-32. PubMed ID: 16422806 [TBL] [Abstract][Full Text] [Related]
14. Chronology of erectile function in patients with early functional erections following radical prostatectomy. Katz D; Bennett NE; Stasi J; Eastham JA; Guillonneau BD; Scardino PT; Mulhall JP J Sex Med; 2010 Feb; 7(2 Pt 1):803-9. PubMed ID: 19796019 [TBL] [Abstract][Full Text] [Related]
15. Erectile dysfunction, discrepancy between high prevalence and low utilization of treatment options: results from the 'Cottbus Survey' with 10 000 men. May M; Gralla O; Knoll N; Fenske S; Spivak I; Rönnebeck C; Hoffmann M; Lenk S; Hoschke B BJU Int; 2007 Nov; 100(5):1110-5. PubMed ID: 17922788 [TBL] [Abstract][Full Text] [Related]
16. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836 [TBL] [Abstract][Full Text] [Related]
17. Patients responding to phosphodiesterase type 5 inhibitor therapy: what do their sexual partners know? Klotz T; Mathers M; Klotz R; Sommer F J Sex Med; 2007 Jan; 4(1):162-165. PubMed ID: 17087808 [TBL] [Abstract][Full Text] [Related]
18. Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys. Travison TG; Hall SA; Fisher WA; Araujo AB; Rosen RC; McKinlay JB; Sand MS J Sex Med; 2011 Nov; 8(11):3051-7. PubMed ID: 21834873 [TBL] [Abstract][Full Text] [Related]
19. Vardenafil: a review of its use in erectile dysfunction. Keating GM; Scott LJ Drugs; 2003; 63(23):2673-703. PubMed ID: 14636086 [TBL] [Abstract][Full Text] [Related]
20. Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile dysfunction. Donatucci C; Taylor T; Thibonnier M; Bangerter K; Gittelman M; Casey R; J Sex Med; 2004 Sep; 1(2):185-92. PubMed ID: 16422973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]